Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOICES trial of DIR/POS/NES in adults with cystic fibrosis without access to approved CFTR modulators
ISRCTN96750019Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- May 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of posaconazole and Nestorone Ring in cystic fibrosis (CF) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Mean percent predicted forced expiratory volume in 1 second. Started May 2024; status: completed.
02
Drugs
posaconazoleNestorone Ring
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ISRCTN96750019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN96750019.